Clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 Clinical Trials

Delta Trials indexes 14 clinical trials for Clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 in its publicly accessible dataset. Of these, 7 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 594 research sites around the world. An additional 6 trials are in preparatory or other active non-recruiting stages. Since 2020, 1 trial were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.